TELAGLENASTAT: 80 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
80
Total FAERS Reports
10 (12.5%)
Deaths Reported
44
Hospitalizations
80
As Primary/Secondary Suspect
7
Life-Threatening
1
Disabilities
First Report: 20170325 · Latest Report: 20210127
What Are the Most Common TELAGLENASTAT Side Effects?
#1 Most Reported
Colorectal cancer metastatic
14 reports (17.5%)
#2 Most Reported
Hypomagnesaemia
6 reports (7.5%)
#3 Most Reported
Therapy partial responder
4 reports (5.0%)
All TELAGLENASTAT Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Colorectal cancer metastatic | 14 | 17.5% | 1 | 0 |
| Hypomagnesaemia | 6 | 7.5% | 1 | 0 |
Who Reports TELAGLENASTAT Side Effects? Age & Gender Data
Gender: 24.7% female, 75.3% male. Average age: 64.1 years. Most reports from: US. View detailed demographics →
Is TELAGLENASTAT Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2017 | 3 | 0 | 3 |
| 2018 | 10 | 1 | 9 |
| 2019 | 28 | 4 | 24 |
| 2020 | 11 | 4 | 7 |
| 2021 | 1 | 0 | 1 |
What Is TELAGLENASTAT Used For?
| Indication | Reports |
|---|---|
| Colorectal cancer metastatic | 25 |
| Renal cell carcinoma | 20 |
| Metastatic renal cell carcinoma | 13 |
| Clear cell renal cell carcinoma | 9 |
Official FDA Label for TELAGLENASTAT
Official prescribing information from the FDA-approved drug label.